Treatment can stop with Ozuma and others … According to the results of the clinical experience of the third stage, it was published on Thursday in the New England magazine. Non -alcoholic fatty liver, caused by excess fat in this organ, is usually treated with obesity, first with delglotida, the base of the drug for diabetes and weight loss, Ozmik. The results include that the fatty liver has decreased by 62.9 % of patients after 72 weeks.
Hepatitis degeneration, as it is known, affects 25 % of the Spanish population, according to data from the Spanish Society for Liver Study (AEH), even children and can lead to cirrhosis, cancer and inflammation. It is a type of liver disease “potentially deadly”.
Semaglutida (found in commercial sects Ozmpic and Wegov) also helped improve liver fibrosis in 36.8 % of patients, to raise liver enzymes and a weight loss of up to 10 %, that the study conducted at King College in London and Virginia Comten (United States). Compared to those who received the imaginary medicine, the article 3 of semaglutida argues in sebaceous hepatitis associated with metabolism “that the improvement indicators are about twice (one in three of their oily liver improvement only with a diet).
Long -term
An investigation was made with 800 patients, half of diabetes and 75 % of excess weight, which was randomly chosen to receive a weekly 2.4 milligram injection of Smaglutida, and advice to improve healthy lifestyle habits. More than 250 medical centers from 37 countries have participated between May and April 2023, and the search line for long -term treatments with OzemPIC will be followed on liver diseases, for a period of five years with about 1,200 patients. Now, the study is funded by the pharmaceutical company developed Ozmpic, Novo Nordisk.
Thanks to the “highly promising” results that “real hope”, as determined by one of the main authors at the work, Philip News, can be a “effective tool” for liver disorders, such as fatty liver (also known for its shortcomings in English, “Mash”). However, it has been reported that OzemPIC caused unwanted side effects such as nausea, diarrhea, constipation and vomiting.
